Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Vanguard Sht-Term Inflation-Protected Sec Idx ETF (VTIP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Vanguard Sht-Term Inflation-Protected Sec Idx ETF — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B), while Vanguard Sht-Term Inflation-Protected Sec Idx ETF trades at $48.46 (market cap $73.20B). The key difference: Vanguard Sht-Term Inflation-Protected Sec Idx ETF is far larger — about 5.8× Halozyme Therapeutics Inc. Common Stock's market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, Vanguard Sht-Term Inflation-Protected Sec Idx ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Vanguard Sht-Term Inflation-Protected Sec Idx ETF for 91 Days on average.
| HALO | VTIP | |
|---|---|---|
Market Cap | $12.58B | $73.20B |
Volume | 2,179,278 | 2,511,360 |
Sector | Health | — |
52-Week High | $115.22 | $50.46 |
52-Week Low | $61.63 | $48.38 |
Typical Hold Time | 1 Days | 91 Days |
Enterprise Value | $14.49B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
VTIP, the Vanguard Short-Term Inflation-Protected Securities ETF, trades at $48.49, up slightly by 0.06% today. The technical outlook is mixed, with a bearish trend from moving averages but bullish signals from oscillators like the RSI. Recent news highlights its role as an inflation hedge amid rising energy prices and Fed policy shifts, with institutional investors increasing positions. Key support sits at $48, with resistance at $49.
The outlook for VTIP is cautiously positive, offering a low-risk inflation hedge with minimal interest-rate sensitivity. Opportunities include protection against persistent inflation and real yield advantages, but risks involve Fed policy uncertainty and potential underperformance if inflation subsides. Investors should weigh its defensive role in a diversified portfolio.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Vanguard Sht-Term Inflation-Protected Sec Idx ETF
The index is a market-capitalization-weighted index that includes all inflation-protected public obligations issued by the US Treasury with remaining maturities of less than 5 years. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the securities that make up the index, holding each security in approximately the same proportion as its weighting in the index.
Read more on VTIP →
